|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 239/42 | (2006.01) |
| A61K 31/5377 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3154950 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15739042.8 |
| Date of filing the European patent application | 2015-06-11 | |
| (97) | Date of publication of the European application | 2017-04-19 |
| (45) | Date of publication and mention of the grant of the patent | 2020-08-05 |
| (46) | Date of publication of the claims translation | 2020-11-25 |
| (86) | Number | PCT/US2015/035316 |
| Date | 2015-06-11 |
| (87) | Number | WO 2015/191846 |
| Date | 2015-12-17 |
| (30) | Number | Date | Country code |
| 201462011315 P | 2014-06-12 | US |
| (72) |
BROWN, Brandon, H., US
CARRA, Ernest, A., US
HEMENWAY, Jeffrey, N., US
MORRISON, Henry, US
REYNOLDS, Troy, US
SHI, Bing, US
STEFANIDIS, Dimitrios, US
WANG, Fang, US
WARR, Matthew, Robert, US
WHITNEY, James, Andrew, US
XIN, Yan, US
|
| (73) |
GlaxoSmithKline LLC,
Corporation Service Company, 251 Little Falls Drive, Wilmington DE 19808,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | N-(cianometil)-4-(2-(4-morfolinofenilamino)pirimidin-4-il)benzamido hidrochlorido druskos |
| N-(CYANOMETHYL)-4-(2-(4-MORPHOLINOPHENYLAMINO)PYRIMIDIN-4-YL)BENZAMIDE HYDROCHLORIDE SALTS |
| Payment date | Validity (years) | Amount | |
| 2025-05-20 | 11 | 289.00 EUR |
| 2026-06-11 |